Use of Proton Pump Inhibitors and risk of gastric cancer

Turk J Gastroenterol. 2018 Jan;29(1):143-144. doi: 10.5152/tjg.2018.17002.

Author

Tarkan Karakan¹

Affiliation

¹ Department of Gastroenterology, Gazi University School of Medicine, Ankara, Turkey.

No abstract available

Publication types

Comment

MeSH terms

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Ulcer Agents
Gastric Acid
Humans
Proton Pump Inhibitors*
Risk
Stomach Neoplasms*

Substances

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Ulcer Agents
Proton Pump Inhibitors